Multivariate analysis for DFS at 2 years
Variable . | P value . | Hazard ratio . | 95% hazard ratio confidence limits . | . | |
---|---|---|---|---|---|
WBCs, × 109/L* | 0.0479 | 1.002 | 1.000 | 1.003 | |
Age, y† | 0.2061 | 1.010 | 0.994 | 1.026 | |
Phenotype, B or T | 0.2924 | 1.385 | 0.755 | 2.533 | |
MDR, negative or positive | 0.7815 | 0.928 | 0.546 | 1.575 | |
Cytogenetic-molecular risk group | |||||
Intermediate vs standard | 0.0428 | 0.552 | 0.311 | 0.981 | |
Intermediate vs high | 0.0231 | 2.006 | 1.100 | 3.659 |
Variable . | P value . | Hazard ratio . | 95% hazard ratio confidence limits . | . | |
---|---|---|---|---|---|
WBCs, × 109/L* | 0.0479 | 1.002 | 1.000 | 1.003 | |
Age, y† | 0.2061 | 1.010 | 0.994 | 1.026 | |
Phenotype, B or T | 0.2924 | 1.385 | 0.755 | 2.533 | |
MDR, negative or positive | 0.7815 | 0.928 | 0.546 | 1.575 | |
Cytogenetic-molecular risk group | |||||
Intermediate vs standard | 0.0428 | 0.552 | 0.311 | 0.981 | |
Intermediate vs high | 0.0231 | 2.006 | 1.100 | 3.659 |